Ophthalmic imaging technology has made significant strides, fundamentally transforming the diagnosis and management of eye diseases. Innovations in ophthalmic imaging and diagnostics now include advanced techniques such as OCT angiography, adaptive optics, and fundus autofluorescence. These technologies provide unparalleled detail, enabling clinicians to detect early signs of conditions like diabetic retinopathy, glaucoma, and macular degeneration. By offering high-resolution imaging of the retina and optic nerve, these tools not only improve diagnostic accuracy but also allow for better disease monitoring over time. As artificial intelligence and machine learning continue to be integrated into these imaging systems, the potential for faster, more accurate diagnoses and more personalized treatment plans is expanding, making early intervention and improved patient outcomes more achievable than ever before.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom